| Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
|---|
| 10/30/2008 | US20080269221 Antibacterial agents |
| 10/29/2008 | EP1985611A1 Process for production of o-methyl-n-nitroisourea |
| 10/29/2008 | EP1985610A1 Improved method for producing nitroisourea derivative |
| 10/29/2008 | EP1492776B1 Iodinated triglyceride analogs |
| 10/29/2008 | CN101296911A Arylurea derivatives as modulators of chemokine receptor activity |
| 10/29/2008 | CN101296897A PPAR modulating biaromatic compounds |
| 10/29/2008 | CN101293858A Method for synthesizing í«dimiliní» with phosgene as raw material |
| 10/23/2008 | US20080262261 Stable liquid biuret modified and biuret allophanate modified toluene diisocyanates, prepolymers thereof, and processes for their preparation |
| 10/23/2008 | US20080261978 treating or preventing HIV infections, and in treating proliferative disorders such as inhibiting the metastasis of various cancers; 1-(4-((pyridin-2-ylmethylamino)methyl)benzyl)-3-phenylurea |
| 10/22/2008 | EP1982985A2 Method for manufacturing a purine derivative |
| 10/21/2008 | US7439393 Phenethanolamine derivatives for treatment of respiratory diseases |
| 10/21/2008 | US7439383 Sodium channel blockers |
| 10/21/2008 | CA2352660C Process for preparing a broad-compatibility, storage-stable, rheologically active urea urethane solution |
| 10/16/2008 | WO2008122667A2 Ureylene derivatives |
| 10/16/2008 | US20080255239 Analgesics; muscular disorders; diarrhea |
| 10/16/2008 | US20080255182 Certain chemical entities, compositions, and methods |
| 10/15/2008 | EP1979309A2 Process for the preparation of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides and intermediates used therein |
| 10/15/2008 | EP1781297B1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 10/15/2008 | CN101284865A New compound and its medicine use |
| 10/09/2008 | US20080249102 Hiv Protease Inhibitors |
| 10/09/2008 | CA2702305A1 Cancer cell targeting using nanoparticles |
| 10/08/2008 | CN101279932A Preparation of N,Ní»-dicyclohexylurea |
| 10/08/2008 | CN101279927A Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
| 10/07/2008 | US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques |
| 10/07/2008 | US7432333 Powder coating of amino-urea or urethane catalyst and epoxy/hydroxy and/or siloxane resin |
| 10/07/2008 | US7432290 Claimed is 1-Cyanobutan-2-yl-1-[3-[3-[3-methoxy-4-(oxazol-5-yl)phenyl]ureido]phenyl] ethylcarbamate, AVN 944, VX-944 |
| 10/02/2008 | US20080242539 Phenol Compound, Reversible Thermosensitive Recording Medium, Reversible Thermosensitive Recording Label, Reversible Thermosensitive Recording Member, Image-Processing Apparatus and Image-Processing Method |
| 10/01/2008 | EP1973872A1 Inhibitors of histone deacetylase and prodrugs thereof |
| 10/01/2008 | EP1973871A1 Diphenyl urea derivatives |
| 09/30/2008 | CA2381001C Carbamate derivative and agricultural/horticultural fungicide |
| 09/30/2008 | CA2303848C Substituted anilides |
| 09/25/2008 | WO2008116145A2 Soluble epoxide hydrolase inhibitors |
| 09/25/2008 | WO2008008433A3 Substituted acylanilides and methods of use thereof |
| 09/25/2008 | WO2007068394A8 Diphenyl urea derivatives |
| 09/25/2008 | US20080234383 Novel Compounds, Isomer Thereof, or Pharmaceutically Acceptable Salts Thereof as Vanilloid Receptor Antagonist; and Pharmaceutical Compositions Containing the Same |
| 09/25/2008 | US20080234320 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 09/23/2008 | CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof |
| 09/18/2008 | WO2008109991A1 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 09/18/2008 | WO2008070496A3 N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| 09/18/2008 | CA2680366A1 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 09/16/2008 | CA2515338C Inhibitors of histone deacetylase |
| 09/12/2008 | WO2008107661A1 New methylenebisphenyl compounds useful in the treatment of inflammation |
| 09/12/2008 | WO2008107475A1 Dialdimine, emulsion containing dialdimine, and bicomponent polyurethane composition, and the use thereof |
| 09/12/2008 | CA2680139A1 New methylenebisphenyl compounds useful in the treatment of inflammation |
| 09/11/2008 | US20080221215 Antiviral inhibition of capsid proteins |
| 09/11/2008 | US20080220003 C5a Receptor Antagonists |
| 09/10/2008 | EP1967510A1 Dialdimine, emulsion containing dialdimine and dual component polyurethane composition and its use |
| 09/10/2008 | CN100417641C Arylcycloalkyl derivatives having branched side chains used as ppar receptor regulator, processes for their preparation and their use as pharmaceuticals |
| 09/09/2008 | US7423175 Vanilloid receptor (VR1) antagonists; side effects reduction, oral availability; To treat urinary incontinence, urge urinary incontinence, overactive bladder, pain, and/or inflammatory diseases such as asthma and COPD; N-[2-(2-Fluorophenoxy)ethyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)-urea |
| 09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 09/09/2008 | CA2305948C Process for preparing a thixotropic agent and its use |
| 09/09/2008 | CA2181689C Guanylhydrazones for treating inflammatory conditions |
| 09/04/2008 | WO2008104756A1 Urea derivatives and their therapeutic use |
| 09/03/2008 | EP1964561A1 Inhibitors of IMPDH enzyme |
| 09/03/2008 | EP1962984A1 Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound |
| 09/03/2008 | CN101255136A 5-cyclopropane toroid hydantoin derivatives as well as preparation method and uses thereof |
| 08/28/2008 | WO2008079683A3 N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain |
| 08/28/2008 | US20080207622 Soluble epoxide hydrolase inhibitors |
| 08/28/2008 | US20080207621 Use treating hypertensive, cardiovascular, inflammatory, pulmonary, and diabetes-related diseases; compounds are aminosulfonylphenyl urea or thiourea e.g. 4-(3-Adamantan-1-yl-ureido)-N-(2-morpholin-4-yl-ethyl)-benzenesulfonamide |
| 08/27/2008 | EP1960352A1 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors |
| 08/27/2008 | CN101250139A Method for synthesizing 3,3'-dimethoxy diphenylurea |
| 08/21/2008 | WO2008099221A1 Amide and urea derivatives for the treatment of metabolic diseases |
| 08/21/2008 | US20080199404 Contrast Agents |
| 08/20/2008 | CN101245037A Process for producing oxygen methyl isourea acetate |
| 08/14/2008 | WO2008079972A3 4-{4- [ ({3-tert-butyl-1- [3- (hydroxymethyl) phenyl] - 1h- pyrazol- 5 -yl } carbamoyl) -amin o] -3-chlorophenoxy} -n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer |
| 08/14/2008 | US20080194650 Aryl fluoroethyl ureas acting as alpha 2 adrenergic agents |
| 08/14/2008 | US20080194645 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 08/14/2008 | US20080194633 E.g., [(1-(2-aminoacetyl)-4-{N-[(3-fluoro-2-methylphenyl)methyl]carbamoyl}(4-piperidyl))methoxy]-N-(4-ethylphenyl)carboxamide; smooth muscle myosin or non-muscle myosin modulator; hypotensive agent; asthma, COPD, bronchoconstrictive disease, glaucoma, pre-menstrual cramps, erectile dysfunction |
| 08/14/2008 | US20080193381 Heterodimers of glutamic acid |
| 08/13/2008 | EP1572632B1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists |
| 08/13/2008 | EP1497263B1 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof |
| 08/13/2008 | EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/07/2008 | US20080188654 Compounds for treatment of inflammation, diabetes and related disorders |
| 08/07/2008 | US20080188489 Cell differentiation inducer |
| 08/06/2008 | EP1951719A2 Certain chemical entities, compositions, and methods |
| 08/06/2008 | EP1311475B1 Aminocyclohexane derivatives |
| 08/06/2008 | CN100408558C Stable liquid biuret modified and biuret allophanate modified toluene diisocyanates, prepolymers thereof, and processes for their preparation |
| 08/06/2008 | CN100408556C Modulation of anxiety through blockade of anandamide hydrolysis |
| 08/05/2008 | US7408079 Imaging agents and methods of imaging NAALADase or PSMA |
| 08/05/2008 | CA2392903C Trans olefinic glucokinase activators |
| 08/05/2008 | CA2337098C Anthranilic acid derivatives |
| 07/31/2008 | WO2008040947A3 Soluble diazoalkane precursors |
| 07/31/2008 | US20080182881 TNF-alpha production inhibitors |
| 07/30/2008 | CN100406007C Asthma and allergic inflammation modulators |
| 07/29/2008 | US7405233 e.g. 3-[3-(4-ISOPROPYLPHENYL)-2,5-DIOXO-IMIDAZOLIDIN-1-YL]-BENZOIC ACID SODIUM SALT; method of modulating premature translation termination and/or nonsense-mediated mRNA decay in a cell in vitro; cystic fibrosis or Duchenne muscular dystrophy |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/24/2008 | US20080176821 phosphoryl-di(glutamate dibenzylester or dihydroxyamide) derivatives; neuroleptic agent, neurodegenerative diseases, neuropathic pain, epilepsy, ischaemia, schizophrenia, amyotrophic lateral sclerosis, Alzheimer's, Parkinson, Huntington diseases; |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/17/2008 | WO2008086047A1 Rho kinase inhibitors |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/17/2008 | CA2674389A1 Rho kinase inhibitors |
| 07/16/2008 | EP1943235A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 07/16/2008 | EP1943213A2 Ppar modulating biaromatic compounds |
| 07/16/2008 | EP1392655B1 Potassium channel openers |
| 07/16/2008 | CN101219972A Method for synthesizing symmetrical aryl urea compounds |
| 07/16/2008 | CN100402492C Androgen receptor suppressors in treatment of hirsutism, acne and androgenetic alopecia |
| 07/15/2008 | US7399866 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 07/15/2008 | US7399788 N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them |
| 07/15/2008 | CA2315258C Neuroprotective agents |